Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00416845 · ClinicalTrials.gov registry record · Phase 1
Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers
A Phase 1 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT00416845 is a Phase 1 study that has completed, run by Novartis. The registered enrollment target is 39 participants.
The verdict
NCT00416845, a Phase 1 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
This study is designed to assess the effects of two doses of FTY720 on lung (pulmonary) and cardiac (heart) functions in healthy volunteers.
Interventions
- DRUG FTY720
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2006-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00416845
The ClinicalTrials.gov registry entry for NCT00416845 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FTY720 is the first listed.
NCT00416845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00416845 about?
NCT00416845 is a clinical study titled "Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers". This study is designed to assess the effects of two doses of FTY720 on lung (pulmonary) and cardiac (heart) functions in healthy volunteers.
What is the current status of trial NCT00416845?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2006-10.
What interventions are being tested in trial NCT00416845?
The interventions under investigation include: FTY720 (DRUG).
Who is sponsoring clinical trial NCT00416845?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.